Literature DB >> 7107394

The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice.

N J McNally, T C Stephens, P R Twentyman, M Hinchliffe, J H Peacock, D Spooner.   

Abstract

Leucopenia is a major dose-limiting effect of many cytotoxic drugs. We have measured the effect of melphalan and four other drugs either alone, or with misonidazole on total white cell count in mice. Three strains were used, though not with all drugs. White cell counts were determined 3, 5, and 7 days after giving the cytotoxic drugs either with or without misonidazole. For all the drugs used, the nadir in white cell count was at 3 to 5 days when the dose-effect curves were approximately expotential. Only in the case of chlorambucil and mitomycin-C did misonidazole enhance the leucopenia. There was no enhancement of the effects of melphalan, cyclophosphamide or CCNU. In the case of mitomycin C the effect of misonidazole was to delay the recovery in the white cell count. It would appear that enhanced leucopenia from the combination of misonidazole with cytotoxic drugs may depend on the drug used. With three of the five drugs, the absence of an effect of misonidazole implies that any enhanced damage to tumors would represent a true increase in therapeutic effectiveness.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107394     DOI: 10.1016/0360-3016(82)90707-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.

Authors:  N J McNally
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

2.  Chemopotentiation in vivo: no loss of sensitization with fractionation.

Authors:  S A Hill; D W Siemann
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

3.  Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.

Authors:  N J McNally; M Hinchliffe; J de Ronde
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.